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Background: High mobility group box 1 (HMGB1) is a late mediator of systemic inflammation. Extracellular HMGB1
play a central pathogenic role in critical illness. The purpose of the study was to investigate the association
between plasma HMGB1 concentrations and the risk of poor outcomes in patients with severe blunt chest trauma.
Methods: The plasma concentrations of HMGB1 in patients with severe blunt chest trauma (AIS ≥ 3) were
measured by a quantitative enzyme-linked immunosorbent assay at four time points during seven days after
admission, and the dynamic release patterns were monitored. The biomarker levels were compared between
patients with sepsis and non-sepsis, and between patients with multiple organ dysfunction syndrome (MODS) and
non-MODS. The related factors of prognosis were analyzed by using multivariate logistic regression analysis. The
short-form 36 was used to evaluate the quality of life of patients at 12 months after injury.
Results: Plasma HMGB1 levels were significantly higher both in sepsis and MODS group on post-trauma day 3, 5,
and 7 compared with the non-sepsis and non-MODS groups, respectively. Multivariate analysis showed that HMGB1
levels and ISS were independent risk factors for sepsis and MODS in patients with severe blunt chest trauma.
Conclusions: Plasma HMGB1 levels were significantly elevated in patients with severe blunt chest trauma. HMGB1
levels were associated with the risk of poor outcome in patients with severe blunt chest trauma. Daily HMGB1
levels measurements is a potential useful tool in the early identification of post-trauma complications. Further
studies are needed to determine whether HMGB1 intervention could prevent the development of sepsis and MODS
in patients with severe blunt chest trauma.
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Trauma is a major cause of mortality and morbidity in
young adults and children in mainland China [1]. Chest
trauma is a common reason for patients to be admitted to
emergency department as a result of serious traffic acci-
dents. Accurate identification of severe chest trauma pa-
tients who have the potential to deteriorate rapidly and
are at risk of developing of post-trauma complications has* Correspondence: lzqsurgery@163.com
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unless otherwise stated.also been difficult. Furthermore, diagnosis of sepsis can be
troublesome in severe traumatic patients as positive bacte-
riologic specimens may be late or absent, the clinical
interpretation of local colonization may be ambiguous,
and traditional infection markers such as core body
temperature and white blood cell counts may show non-
specific alterations [2].
A number of inflammatory cytokines, such as interleu-
kin (IL)-1, IL-6, and IL-8, tumor necrotizing factor
(TNF-α), which are involved in systemic inflammation
caused by trauma, infection, cancer, chronic disease, and
surgery [3], have been assessed for their roles as poten-
tial markers of the severity of inflammatory response.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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originally as a nonhistone nuclear deoxyribonucleic acids
binding protein has been identified as an important late
mediator of systemic inflammation in contrast to other
inflammatory cytokines mentioned. It has been demon-
strated that HMGB1 plays a key pathogenic role in the
pathogenesis of sepsis and multiple organ dysfunction
syndrome (MODS) in critical illness including major
trauma [4–8]. Therefore, HMGB1 is an interesting can-
didate marker for monitoring patients with severe chest
blunt trauma.
However, we are lacking knowledge about the changes
in HMGB1 levels during the course of severe blunt chest
trauma or its relationship with the extent of trauma and
the prognosis of those patients. The aim of the study was
to investigate the time course of HMGB1 levels in patients
with blunt chest trauma and to determine whether the
levels of HMGB1 were associated with the risk of sepsis
and MODS after severe blunt chest trauma.
Methods
We undertook a prospective cohort study in between
April 2011 and January 2012. All consecutive eligible pa-
tients were admitted to our surgical ICU and a detailed
questionnaire assessing the medical history and physical
state of the patients were filled out by an experienced
physician. The study was strictly observational and did
not interfere the decision-making process and clinical
management. Patients were treated according to the
standard management without having any reference to
the response tends of HMGB1 in their clinical evalu-
ation. The protocol for this study was approved by the
Ethical and Protocol Review Committee of the Chong-
qing Medical University, Chongqing, China, and in-
formed consent was obtained from all patients or their
next of kin. Patient confidentiality was preserved accord-
ing to the guidelines for the studies of human subjects.
All of the participants were Han Chinese.
Inclusion and exclusion criteria
Criteria for inclusion in the study were age ≥ 16, blunt
chest trauma with a severe thoracic trauma (AISchest) ≥
3, primary admission to the hospital within 24 h after in-
jury (time of injury is defined as the time of pre-hospital
emergency medical service activation), and survival fol-
lowing the trauma of more than seven days. Multiple
trauma patients meeting the criteria were also admitted.
Exclusion criteria were penetrating trauma, steroidal and
non-steroidal anti-inflammatory medication therapy.
Clinical evaluation and definitions
Multiple rib fracture was defined as breakage of 3 or
more ribs, and flail chest was a traumatic condition in
which there are three or more contiguous ribs withfractures in two or more places [9]. Sepsis was diagnosed
when patients met all of the following criteria: clinical
evidence of infection, body temperature above 38.5°C or
below 36.5°C, and leukocyte count greater than 10 × 109/
l or less than 4 × 109/l. MODS is usually defined as a
Marshall score of 4 or more for at least 2 consecutive
days [10]. Stricter definition of MODS as a Marshall
score of 6 or more was used in this study. Scores for
MODS were calculated as the sum of the simultaneously
obtained individual organ scores during the first week of
ICU stay [11]. The bloodstream infections were diagnosed
according to the isolation of a predominant organism
from blood cultures obtained under sterile conditions.
Clinical data collection
Data, including demographic characteristics, medical
histories, mechanism of injury, injury diagnoses, injury
severity score (ISS), chest abbreviated injury score
(AISchest), management, and clinical course, were col-
lected by a structured patient interview. Determination
of ISS and AIS were performed by independent evalua-
tors according to the Abbreviated Injury Scale 2005 [12].
The traumatic patients were stratified into two groups
according to ISS: higher injury severity scores (ISS 20 or
more) group and lower injury severity scores (ISS 20 or
less) group. Alternatively, patients were divided into sep-
sis group and non-sepsis group according to develop-
ment of sepsis, or MODS group and non-MODS group
based on the MODS score. The quality of life health sur-
vey (using the Chinese version of Short Form [SF 36])
was taken 12 months after injury.
Blood sample collection
Venous peripheral blood was drawn from patients on
post-trauma days 1, 3, 5 and 7. Samples were collected
in potassium ethylenediamine tetra-acetic acid (EDTA)
coated bottles, and were centrifuged at 5,000 g for 5 mi-
nutes to remove the cellular components. The plasma
obtained was stored at −80°C for longer term storage.
Samples assay
The plasma samples were tested for HMGB1 levels by
enzyme-linked immunosorbent assay (ELISA), using a
commercially available human HMGB1 ELISA kit
(USCN Life Sciences, Wuhan, Hubei, China), and ac-
cording to the manufacturer’s instruction. The minimum
detectable level of HMGB1 was 12 pg/ml. The dilution
curve of the plasma samples was parallel to the standard
dilution curve.
Statistical analysis
Differences between groups were evaluated by Student
t test for continuous variables and by χ2 test or Fisher exact
for categorical variables. Logistic regressions were used as
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ISS, pneumo/hemomediastinum, and tracheotomy. All stat-
istical tests were two sided, and P value < 0.05 was consid-
ered statistically significant. Statistical analyses were
performed using SPSS 16.0 (SPSS, Chicago, Illinois, USA).
Results
Study sample and injury-related characteristics
In the study, a total of 57 patients with blunt chest
trauma were recruited and the mean age was 44.4 ± 12.6.
41 patients (71.9%) were male and 16 (28.1%) were fe-
male. The mean ISS was 17.4 ± 6.1 and the mean AISch-
est was 3.5 ± 0.5. The main patients’ demography and
clinical data were presented in Table 1. Of the patients
who were initially evaluated, 26 patients were excluded
from the study due to the following reasons: admission
later than 24 hours after trauma (n = 5), died within
7 days (n = 3), age younger than 16 years (n = 4), pene-
trating trauma (n = 5), and did not have post-trauma
blood sample available (n = 9).
Out of the 57 trauma cases, 35 patients (61.4%) were
due to motor vehicle crashers, 17 (29.8%) were caused
by falling and 5 (8.8%) were by other trauma. 13 patients
had blunt chest trauma only and 44 had multiple injur-
ies. Multiple rib fractures were present in 54 patients
(94.7%) and 9 of them (15.8%) had flail chest. Pleural al-
terations were observed in 52 (91.2%) cases, in which
35 were of pneumothorax (61.4%), 51 of hemothorax
(89.5%), and 25 of hemopneumothorax (43.9%). Pulmon-
ary contusion was evident radiographically in 50 (87.8%),
and among them, there were 24 cases of bilateral pul-
monary contusion (42.1%).
Overall, 14 patients (24.5%) developed sepsis, 5 pa-
tients (8.8%) MODS, and two of these patients died.
47 (82.5%) patients in total required tube thoracostomy,
12 (21.2%) were treated surgically by thoracotomy as
illustrated in Table 1, and tracheotomy rate was 15.8%
(n = 9). The length of intensive care unit (ICU) and hos-
pital stay were 11.5 ± 8.6 day and 57.6 ± 28.8 days, respect-
ively. Long-term follow-up was complete for 52 patients
(91.2%). Mean follow-up time was 16.7 ± 4.1 months.
Changes in HMGB1 levels after trauma
Figure 1 shows the plasma levels of HMGB1 at various
time points. The mean plasma HMGB1 levels in blunt
chest trauma patients on post-trauma day 1 were 43.8 ±
13.1 ng/ml, day 3 (65.7 ± 27.6 ng/ml), day 5 (72.5 ±
29.8 ng/ml), day 7 (74.4 ± 28.3 ng/ml). The overall pat-
terns of plasma concentration of HMGB1 were increased
in patients on day 1, peaked on day 5 and remained ele-
vated through the consecutive 7 days.
Table 1 summarized the clinical characteristics of the
two groups. The group with ISS ≥ 20 had a higher pro-
portion of patients with pneumothorax (85.7% vs. 47.2%,P = 0.004), bilateral pulmonary contusion (61.9% vs. 30.6%,
P = 0.021), thoracotomy (38.1% vs. 11.1%, P = 0.016), and
tracheotomy (38.1 vs. 2.8%, P < 0.001). In a 12 months
follow-up, patients in the group with ISS < 20 group had
significantly better physical component summary of SF 36
(71.3 ± 5.5 vs. 64.7 ± 7.0, P = 0.001).
As shown in Figure 2, the HMGB1 levels were signifi-
cantly higher in high ISS group than those with lower
ISS during day 3 to 7. In patients with an ISS ≥ 20, there
were no statistically significant difference in mean
HMGB1 levels on day 1 (45.3 ± 10.7 ng/ml vs 42.5 ±
15.1 ng/ml, P = 0.41), whereas there were statistically sig-
nificant increase in mean HMGB1 levels on days 3, 5,
and 7 compared with those with ISS 20 or less (Day 3:
74.3 ± 29.8 ng/ml vs 57.4 ± 22.9 ng/ml, P = 0.02; Day 5:
82.1 ± 29.6 ng/ml vs 63.4 ± 27.6 ng/ml, p = 0.018; Day 7:
84.9 ± 31.4 ng/ml vs 64.3 ± 27.6 ng/ml, P = 0.011).
Plasma levels of HMBG1 related with sepsis and MODS
A higher proportion of patients in the sepsis and MODS
groups had flail chest (50% vs. 4.7%, P < 0.001; 60% vs.
13.5%, P = 0.033), mechanical ventilation (64.3% vs. 4.7%,
P < 0.001; 60% vs. 15.4%, P = 0.045), thoracotomy (64.3%
vs. 7.0%, P < 0.001; 60.0% vs. 17.3%, P = 0.045), tracheot-
omy (42.9% vs. 7.0, P = 0.001; 60% vs. 11.5%; P = 0.025)
compared with non-sepsis and non-MODS groups, re-
spectively. Moreover, more patients in the MODS group
had pneumo/hemomediastinum (60% vs. 7.7%, P =
0.011). The physical component summary of the SF 36
was significantly worse for patients in sepsis and MODS
groups than for those in non-sepsis and non-MODS
groups (all P < 0.05, Table 1).
Figure 3 showed that statistically significantly higher
HMGB1 levels on post-trauma day 3, 5 and 7 were ob-
served in patients who developed sepsis (all P < 0.001),
but the levels were not significantly different on day 1
between sepsis patient (48.4 ± 12.3 ng/ml) and non-
sepsis patient (42.2 ± 10.3 ng/ml) (P = 0.12). In contrast,
patients in MODS group had significantly higher HMGB1
levels when compared with those of non MODS group on
the first day (53.2 ± 9.3 ng/ml vs 42.7 ± 13.1 ng/ml [P =
0.042]), the third day (97.3 ± 23.1 ng/ml vs 62.0 ± 25.8 ng/
ml [P = 0.001]), the fifth day (117.4 ± 13.7 ng/ml vs 67.3 ±
26.6 ng/ml [P < 0.001]), the seventh day (129.8 ± 13.6 ng/
ml vs 67.9 ± 25.3 ng/ml [P < 0.001]) (Figure 4).
Multivariate analysis
The association of plasma HMGB1 levels with the risk of
sepsis and MODS was assessed after adjusting for poten-
tial confounding variables in multivariate analyses. The re-
sults showed that the HMGB1 level and ISS were
independent risk factors for the development of sepsis
[1.89 (95% CI, 1.25 ~ 2.91; P = 0.003); 2.23 (95% CI, 1.22 ~
4.08; P = 0.011)] and MODS of chest trauma patients [1.78
Table 1 Demographic and clinical characteristics of the patients
Variable Total ISS <20 ISS ≥ 20 Sepsis group Non sepsis group MODS group Non MODS group
Gender
Female 16 (28%) 10 (27.8%) 6 (28.6%) 2 (14.3%) 14 (32.6%) 0 (0) 16 (30.8%)
Male 41 (72%) 26 (72.2%) 15 (71.4%) 12 (85.7%) 29 (76.4%) 5 (100%) 36 (69.2%)
Age (years) 44.4 ± 12.6 43.1 ± 9.9 46.8 ± 16.2 42.4 ± 18.7 45.1 ± 10.1 47.3 ± 19.8 42.1 ± 13.4
Mechanism of injury
Motor vehicle crasher 35 (61%) 24 (66.7%) 11 (52.4%) 6 (42.9%) 29 (67.4%) 4 (80.0%) 31 (59.6%)
Falls 17 (30%) 8 (22.2%) 9 (42.9%) 8 (57.1%) 9 (20.9%) 1 (20.0%) 16 (30.8%)
other 5 (9%) 4 (11.1%) 1 (4.8%) 0 (0%) 5 (11.6%) 0 (0) 5 (9.6%)
AIS Chest 3.5 ± 0.5 3.2 ± 0.06 3.9 ± 0.08
** 3.71 ± 0.47# 3.35 ± 0.53 3.92 ± 0.71 3.29 ± 0.42
ISS 17.4 ± 6.1 13.4 ± 2.97 24.2 ± 3.8** 22.0 ± 5.0## 15.8 ± 5.8 26.8 ± 4.81&& 16.3 ± 4.25
Pneumo/Hemomediastinum 7 (12%) 2 (5.6%) 5 (23.8%) 3 (21.4%) 4 (9.3%) 3 (60%)& 4 (7.7%)
Head/Brain injury 36 (63%) 21 (58.3%) 15 (71.4%) 10 (71.4%) 26 (60.5%) 3 (60%) 33 (63.5%)
Abdominal injury 20 (35%) 12 (33.3%) 8 (38.1%) 4 (28.6%) 16 (37.2%) 3 (60%) 17 (32.7%)
Extremities/pelvis injury 22 (39%) 11 (30.6%) 11 (52.4%) 5 (35.7%) 17 (39.5%) 1 (20%) 21 (40.4%)
Multiple rib fractures 54 (95%) 34 (94.4%) 20 (95.2%) 14 (100%) 40 (93.6%) 5 (100%) 49 (94.2%)
Flail chest 9 (16%) 3 (8.3%) 6 (28.6%) 7 (50.0)## 2 (4.7%) 3 (60%)& 7 (13.5%)
Pneumothorax 35 (62%) 17 (47.2%) 18 (85.7%)* 11 (78.6%) 24 (55.8%) 5 (100%) 30 (57.7%)
Hemothorax 51 (90%) 32 (88.9%) 19 (90.5%) 13 (92.9%) 38 (88.4%) 5 (100%) 46 (88.5%)
Hemopneumothorax 25 (44%) 13 (36.1%) 12 (57.1%) 9 (64.3%) 16 (37.2%) 4 (80.0%) 21 (40.4%)
Pulmonary contusion 50 (88%) 30 (83.3%) 20 (95.2%) 14 (100%) 36 (83.7%) 5 (100%) 45 (86.5%)
Bilateral pulmonary contusion 24 (42%) 11 (30.6%) 13 (61.9%)* 9 (64.3%) 15 (34.9%) 4 (80.0%) 20 (38.5%)
Tube thoracostomy 47 (83%) 27 (75.0%) 20 (95.2%) 14 (100%) 33 (76.7%) 5 (100%) 42 (80.8%)
Mechanical ventilation 11 (19%) 2 (5.6%) 9 (42.9%) 9 (64.3%)## 2 (4.7%) 3 (60.0%)& 8 (15.4%)
Thoracotomy 12 (21%) 4 (11.1%) 8 (38.1%)* 9 (64.3%)## 3 (7.0%) 3 (60.0%)& 9 (17.3%)
Tracheotomy 9 (16%) 1 (2.8%) 8 (38.1%)* 6 (42.9%)# 3 (7.0%) 3 (60.0%)& 6 (11.%)
SF 36a
PCS 68.4 ± 6.8 71.3 ± 5.5§ 64.7 ± 7.0 63.6 ± 6.7§ 70.6 ± 6.0 59.3 ± 7.1§ 69.8 ± 8.2
MCS 76.3 ± 8.4 77.6 ± 8.1 74.4 ± 8.7 72.6 ± 9.0 77.5 ± 7.9 70.4 ± 11.2 77.1 ± 10.1
Data are presented as mean ± standard deviation or percentage (%).
ISS: Injury Severity Score; VATS: Video-Assisted Thoracoscopic Surgery; PCS: Physical component summary; MCS: Mental component summary.
aMeasures general aspects of health; scores range from 0 to 100, with higher scores representing better well-being (§P < 0.01).
Significant difference between ISS < 20 group and ISS ≥ 20 group (*P < 0.05; **P < 0.01); Significant difference between Sepsis group versus Non-Sepsis group
(#P < 0.05; ##P < 0.01); Significant difference between MODS group versus Non-MODS group (&P < 0.05).
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P = 0.035)] (Table 2).
Discussion
The pathophysiologic stress of trauma would result in
elevated HMGB1 production and that higher circulating
levels of HNGB1 would be associated with the occur-
rence of poor outcome. This study showed markedly
high plasma levels of HMGB1 in all patients with severe
blunt chest trauma, and a significant association be-
tween higher plasma HMGB1 levels and the risk of sep-
sis and MODS after injury. Furthermore, higher levels of
plasma HMGB1 were independently associated with a
diagnosis of sepsis and MODS. The finding of strongcorrelation between with high HMGB1 levels and prog-
nosis in patients with severe blunt chest trauma suggests
that HMGB1, as an important late mediator of systemic
inflammation, might play a role in the pathogenesis of
sepsis and MODS.
Blunt injuries of chest wall are very common in clin-
ical practice. Chest trauma is classified as blunt and
penetrating injuries, and that 30% to 40% of the trauma
patients required hospitalization [13]. Furthermore,
chest injuries are directly responsible for 20% - 25% of
all trauma-related deaths [14,15], which translates to ap-
proximately 25,000 deaths in the United States [13,16],
and 150,000 in China each year. Blunt chest wall trauma


















Figure 1 Time course of HMGB1 levels after trauma. Mean high-
mobility group box 1 levels were gradually increased during day 1–7





















Non Sepsis ****  
**  
Figure 3 Comparison of HMGB1 plasma levels in patients with
or without sepsis. HMGB1: high-mobility group box 1. **, p < 0.001.
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fracture to severe crush injuries on both sides of the
thorax, which can be lead to potentially fatal respiratory
compromise [17]. Blunt forces applied to the chest wall
cause trauma by three mechanisms: rapid deceleration,
direct impact, and compression. The most common
cause of blunt chest trauma is the motor vehicle acci-
dent, accounting for 70%-80% of blunt thoracic injuries
[14]. This study showed that 61.4% of the trauma cases
were caused by motor vehicle collisions. The rate is
lower than previous research reports, probably due to a
number of approaches employed in prevention motor
vehicle accidents, like speed limit enforcement, passive
restraints, and drunken driving legislation which have
been increasingly effective in China.
Clinical and experimental data indicated that the exist-
ence of a severe inflammatory response on trauma that
could lead to a secondary injury progressing within days.
Blunt chest trauma induces systemic inflammatory re-
sponse, and it is often associated with sepsis in the late
phase of the trauma, which can lead to post-trauma
complication contributing to poor outcome. The most
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ISS 20 or less **  **  
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Figure 2 Comparison of HMGB1 plasma levels in patients with
ISS 20 or above vs those with ISS 20 or less. ISS: injury severity
score; HMGB1: high-mobility group box 1. **, p < 0.001.for therapeutic intervention have not yet been identi-
fied. The question about the most suitable risk factors
for the prognosis assessment of thoracic trauma re-
mains. Moreover, there are a few studies examining the
role of HMGB1 in the pathophysiological mechanisms
of blunt chest trauma. This study has demonstrated
that plasma HMGB1 levels were associated with the
risk of post-trauma sepsis and MODS in blunt chest
trauma patients.
HMGB1 has been demonstrated to play a central role
in the initiation and propagation of the inflammatory re-
sponse in traumatic injury. Wang et al. demonstrated
that the persistent increase of plasma HMGB1 in septic
patients is correlated with the degree of organ dysfunc-
tion and outcome [7]. Furthermore, Peltz et al. found
that Plasma HMGB1 is significantly increased within 1 h
of mechanical trauma in humans, and an increased
HMGB1 level is associated with requiring longer dur-
ation of intensive care unit (ICU) stays in trauma pa-
tients [18]. The increased plasma HMGB1 contributes to
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 #
Figure 4 Comparison of HMGB1 plasma levels in patients with
or without MODS. MODS: multiple organ dysfunction syndrome.
HMGB1: high-mobility group box 1; MODS: multiple organ
dysfunction syndrome. #, p < 0.05; **, p < 0.001.




valueOdds ratio (95% CI) Odds ratio (95% CI)
HMGB1 1.89 (1.25 ~ 2.91) 0.003 1.78 (1.03 ~ 2.87) 0.017
ISS 2.23 (1.22 ~ 4.08) 0.011 2.07 (1.44 ~ 3.95) 0.035
Tracheotomy 0.67 (0.42 ~ 1.05) 0.094 — —
Presence pneumo/hemomediastinum — — 0.84 (0.47 ~ 1.02) 0.052
HMGB1: High mobility group box 1; ISS: Injury Severity Score; MODS: multiple organ dysfunction syndrome.
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days in patients with sepsis [5], and HMGB1 expression
correlates with poor outcome in lung injury patients
[20]. Our study, in agreement with previous reports,
noted that a higher HMGB1 concentration was associ-
ated with the risk of developing sepsis and MODS in pa-
tients with chest trauma. Additionally, a great number of
evidence has shown that burn injury induces an eleva-
tion in plasma HMGB1 concentration [21–23].
As shown in our study, the difference in plasma
HMGB1 concentrations between blunt chest trauma
patients with and without poor outcome (such as sep-
sis, and MODS) was significant. The plasma levels of
HMGB1 in patients who developed sepsis remained at
the same level throughout the course of the study.
Plasma levels of HMGB1 in patients with MODS dur-
ing the study increased from post-trauma day 1 to 7.
On the first day of trauma, there was no difference be-
tween the post-trauma infection and non-infection
groups. However, from day 3 to day 7, there was a sta-
tistically significant difference between the two groups.
Plasma levels of HMGB1 from day 3 could be a useful
marker of clinical outcome.
Global trauma scorings systems, such as the Injury Se-
verity score (ISS) and the Revised Trauma score (RTS),
are the current standards for assessing the severity of
trauma [24,25]. Besides ISS, the Abbreviated Injury scale
is the most common and clinically used scoring system,
which provides more trauma-related assessment. Simi-
larly, the association between plasma HMGB1 levels and
the ISS was also identified in our study.
To our knowledge, blood lactate monitoring is widely
used as a primary biomarker of tissue hypoxia in the as-
sessment of the traumatized patient and the critically ill
patient admitted to Emergency Department (ED). Sev-
eral studies have demonstrated lactate measurements,
assessed at admission to ED or trauma centre, as being
useful in terms of predicting adverse outcome [26–29].
Unfortunately, we did not measure lactate levels in this
study. However, we could hypothesize that the com-
bined measurement of HMGB1 and lactate can better
predict in-hospital morbidity and mortality in patients
with trauma.There are still some limitations in our study. Firstly,
the sample size of blunt chest trauma patients was rela-
tively small in this study. Future studies in a larger pa-
tient population might be needed to further validate
their clinical association. In addition, sepsis and MODS
could be a cause rather than a consequence of higher
substrate levels. Furthermore, there were difficulties in
obtaining enough blood samples from these patients,
which hindered our investigation into the kinetics of
plasma HMGB1 levels in long period. Finally, the pa-
tients recruited in this study cohort were limited to the
Chongqing district. We lack comparison with some bio-
markers, such as C-reactive protein, TNF-α, procalcitonin.
Conclusion
In summary, plasma HMGB1 levels were significantly
elevated in patients with blunt chest trauma and pa-
tients with higher levels of HMGB1 had more severe
trauma, as well as a greater number of post-trauma
complications incidences. Pathophysiology following
blunt chest trauma is complex and influenced by both
patient-specific factors and trauma-specific factors.
Therefore, one single parameter will not be able to ad-
equately predict the clinical course of chest traumatized
patients. However, the study supports that HMGB1
might play an important role in the pathogenesis of
sepsis and MODS after blunt chest trauma. Our study
demonstrated that daily HMGB1 measurements might
be a potential useful tool in the early identification of
post-trauma complications. Further studies are needed
to determine whether HMGB1 intervention could pre-
vent the development of poor outcome in patients with
severe blunt chest trauma.
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